Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Folke Folkvaljon

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 24, 2020
Breast reconstruction patterns from a Swedish nation-wide surveyDmytro Unukovych, Rojda Gümüscü, Fredrik Wärnberg, et al.
Muscle & Nerve|November 18, 2024
Estimating Meaningful Differences in Measures of Neuropathic Impairment, Health-Related Quality of Life, and Nutritional Status in Patients With Hereditary Transthyretin AmyloidosisFolke Folkvaljon, Morie Gertz, Julian D Gillmore, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 18, 2024
Effects of eplontersen on symptoms of autonomic neuropathy in hereditary transthyretin-mediated amyloidosis: secondary analysis from the NEURO-TTRansform trialJonas Wixner, John L Berk, David Adams, et al.
Journal of Cardiac Failure|November 27, 2024
Wearable Accelerometer-Derived Measures of Physical Activity in Heart Failure: Insights From the DETERMINE trialsKieran F Docherty, Ruben Buendia Lopez, Folke Folkvaljon, et al.
Circulation. Heart Failure|August 30, 2024
Effect of Dapagliflozin on Accelerometer-Based Measures of Physical Activity in Patients With Heart Failure: An Analysis of the DETERMINE TrialsKieran F Docherty, Ruben Buendia Lopez, Folke Folkvaljon, et al.
European Journal of Heart Failure|July 20, 2023
Rationale and design of ENDEAVOR: A sequential phase 2b-3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fractionLars H Lund, Carolyn S P Lam, Patricia E Pizzato, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 24, 2020
Breast reconstruction patterns from a Swedish nation-wide surveyDmytro Unukovych, Rojda Gümüscü, Fredrik Wärnberg, et al.
Muscle & Nerve|November 18, 2024
Estimating Meaningful Differences in Measures of Neuropathic Impairment, Health-Related Quality of Life, and Nutritional Status in Patients With Hereditary Transthyretin AmyloidosisFolke Folkvaljon, Morie Gertz, Julian D Gillmore, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 18, 2024
Effects of eplontersen on symptoms of autonomic neuropathy in hereditary transthyretin-mediated amyloidosis: secondary analysis from the NEURO-TTRansform trialJonas Wixner, John L Berk, David Adams, et al.
Journal of Cardiac Failure|November 27, 2024
Wearable Accelerometer-Derived Measures of Physical Activity in Heart Failure: Insights From the DETERMINE trialsKieran F Docherty, Ruben Buendia Lopez, Folke Folkvaljon, et al.
Circulation. Heart Failure|August 30, 2024
Effect of Dapagliflozin on Accelerometer-Based Measures of Physical Activity in Patients With Heart Failure: An Analysis of the DETERMINE TrialsKieran F Docherty, Ruben Buendia Lopez, Folke Folkvaljon, et al.
European Journal of Heart Failure|July 20, 2023
Rationale and design of ENDEAVOR: A sequential phase 2b-3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fractionLars H Lund, Carolyn S P Lam, Patricia E Pizzato, et al.
Pageof 2